← Open Payments lookup

AMANDA EYMARD: Open Payments

NPI 1790162626 · HOUMA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$164,238 in 350 payments from 13 companies in 2025. Trend: 2023 $120,908 · 2024 $181,355 · 2025 $164,238

Speaker / faculty: $97,057Honoraria: $33,638Travel & lodging: $15,427Consulting: $11,278Food & beverage: $6,608Education: $231
CompanyPaymentsAmount
Axsome Therapeutics, Inc.73$38,095
Neurocrine BioSciences, Inc.59$37,737
Otsuka America Pharmaceutical, Inc.71$36,896
Alkermes, Inc.72$28,064
Teva Pharmaceuticals USA, Inc.38$19,381
ABBVIE INC.15$3,495
E.R. Squibb & Sons, L.L.C.10$183
Janssen Scientific Affairs, LLC1$143
Janssen Pharmaceuticals, Inc6$137
Corium, LLC2$34

Products named: Auvelity, INGREZZA, REXULTI, UZEDY, ARISTADA, LYBALVI, VRAYLAR, COBENFY.

Industry payments across LA — which companies pay providers there.